SRRK
Scholar Rock Holding Corporation Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Scholar Rock (SRRK) Stock: Buy, Sell, or Hold?
$46.60
-1.40 (-2.92%)
▼
5d:
+1.11%
30d:
+15.0%
90d:
-12.17%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 10, 2026
0d
Protect SRRK Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (26%)
Quality Score
32/100
Position
EXTENDED
30-Day Fair Range
$40.57 – $45.87
Position: EXTENDED
Forward P/E & Valuation
-17.8x
Next 12M consensus est.
Wall Street Target
$70.44
+51.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$42.89 / $52.25
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: SRRK shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When SRRK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SRRK is currently trading at $46.60, which is considered extended relative to its 30-day fair value range of $40.57 to $45.87.
Technical Outlook: Technically, SRRK is in a strong downtrend. Immediate support is located at $42.89, while resistance sits at $52.25.
Market Sentiment: SRRK scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $70.44 (+51.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SRRK is in a strong downtrend. Immediate support is located at $42.89, while resistance sits at $52.25.
Market Sentiment: SRRK scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $70.44 (+51.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$40.57 -
$45.87
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
Trading Range & Key Levels
30-Day Trading Range
$40.57 -
$45.87
Current vs Trading Range
EXTENDED
Support Level
$42.89
Resistance Level
$52.25
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding SRRK? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 51.2% below Wall St target ($70.44)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-17.75
Wall Street Target
$70.44
(+51.2%)
Revenue Growth (YoY)
-100.0%
Share SRRK Analysis
Share this live SRRK analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SRRK)
Bearish
5 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
4 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate bullish sentiment towards $SRRK, with traders sharing testimonials, professional overviews, and patient approval stories for the drug Ismestyl. No recent news articles were found.
Key Retail Themes:
Positive testimonials and experiences with Ismestyl
Anticipation for the drug's potential approval and commercial success
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:52 PM ET
Data refreshes hourly during market hours. Next update: 8:52 PM
Data refreshes hourly during market hours. Next update: 8:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRRK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 49 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 33 SELL |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 34 SELL |
|
RAPP
Rapport Therapeutics, In… |
STRONG BUY
16 analysts |
$64 | 45 HOLD |
Advanced SRRK Option Strategies
Professional options setups generated by AI based on today's SRRK price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SRRK Research Pages
